Patents by Inventor Max Fabian Felle

Max Fabian Felle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240093211
    Abstract: The present invention generally relates to the field of fermentation technology and microorganisms useful for such fermentations. The invention also relates to materials including nucleic acids and proteins useful for altering fermentation characteristics of microorganisms, and to microorganisms comprising such nucleic acids and/or proteins.
    Type: Application
    Filed: September 8, 2023
    Publication date: March 21, 2024
    Inventors: Max Fabian Felle, Stefan Jenewein, Kerstin Hage, Holger Hartmann
  • Publication number: 20240060110
    Abstract: The present invention provides a modified Bacillus cell for the production of a compound of interest, wherein the Bacillus cell comprises a genetic modification that leads to decreased production of enzymes with lipase and/or esterase activity. The use of compounds of interest produced with said improved Bacillus host cells reduces the formation of malodour and/or off-flavour when used for applications such as washing or cleaning or as feed or food additives.
    Type: Application
    Filed: October 6, 2021
    Publication date: February 22, 2024
    Inventors: Stefan Jenewein, Max Fabian Felle, Christopher Sauer, Paul Igor Costea
  • Patent number: 11788094
    Abstract: The present invention generally relates to the field of fermentation technology and microorganisms useful for such fermentations. The invention also relates to materials including nucleic acids and proteins useful for altering fermentation characteristics of microorganisms, and to microorganisms comprising such nucleic acids and/or proteins.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: October 17, 2023
    Assignee: BASF SE
    Inventors: Max Fabian Felle, Stefan Jenewein, Kerstin Hage, Holger Hartmann
  • Publication number: 20230295603
    Abstract: The present invention relates to a bacterial host cell in which a first chromosomal gene encoding a first alanine racemase and a second chromosomal gene encoding a second alanine racemase have been inactivated. Said bacterial host cell comprises – either on a plasmid comprising at least one autonomous replication sequence or present as multiple copies in the chromosome – a gene expression cassette comprising a polynucleotide encoding at least one polypeptide of interest, operably linked to a promoter, and a polynucleotide encoding a third alanine racemase, operably linked to a promoter. The present invention further relates to a method for producing at least one polypeptide of interest based on cultivating the bacterial host cell of the present invention.
    Type: Application
    Filed: July 23, 2021
    Publication date: September 21, 2023
    Inventors: Max Fabian Felle, Stefan Jenewein, Christopher Sauer, Tobias Klein
  • Publication number: 20230272358
    Abstract: The present invention relates to a Bacillus host cell belonging to the species Bacillus lichemformis or Bacillus pumilus in which the chromosomal alr gene has been inactivated. Said bacterial host cell comprises a plasmid comprising at least one autonomous replication sequence, a first polynucleotide encoding at least one polypeptide of interest, wherein said first polynucleotide is operably linked to a promoter, and a second polynucleotide encoding an alanine racemase which is not native to the host cell, wherein said second polynucleotide is operably linked to a promoter. The present invention further relates to a method for producing at least one polypeptide of interest based on cultivating the bacterial host cell of the present invention.
    Type: Application
    Filed: July 23, 2021
    Publication date: August 31, 2023
    Inventors: Stefan Jenewein, Max Fabian Felle, Christopher Sauer, Tobias Klein
  • Publication number: 20230227834
    Abstract: Described herein are materials and methods for user-controlled adjustment of plasmid copy numbers.
    Type: Application
    Filed: June 17, 2021
    Publication date: July 20, 2023
    Inventors: Max Fabian Felle, Christopher SAUER, Karen STETTER, Diana WOLF, Thorsten MASCHER
  • Publication number: 20230212593
    Abstract: Disclosed herein are methods for the production of low to medium expressing constitutive promoters in bacteria and promoters produced therewith.
    Type: Application
    Filed: March 1, 2021
    Publication date: July 6, 2023
    Inventors: Max Fabian FELLE, Christopher SAUER, Norma WELSCH, Mathis APPELBAUM, Thomas SCHWEDER
  • Publication number: 20230183686
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: September 16, 2022
    Publication date: June 15, 2023
    Inventors: Leendert W. Neuteboom, John A. McElver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle
  • Publication number: 20230139192
    Abstract: Disclosed herein is a shuttle vector for use in E. coli and Bacilli including a high copy replication origin functional in E. coli, a low to medium copy ORI functional in Bacilli, and a synthetic constitutive regulatory nucleic acid conferring reduced constitutive expression compared to a respective starting regulatory nucleic acid molecule in a bacterial cell.
    Type: Application
    Filed: March 1, 2021
    Publication date: May 4, 2023
    Inventors: Max Fabian FELLE, Christopher SAUER, Norma WELSCH, Mathis APPELBAUM, Thomas SCHWEDER
  • Publication number: 20230107997
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: September 16, 2022
    Publication date: April 6, 2023
    Inventors: Leendert W. NEUTEBOOM, John A. MCELVER, Rosa DE PINHO BARROCO, Chris DE WILDE, Max Fabian FELLE
  • Patent number: 11608499
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: March 21, 2023
    Assignee: BASF PLANT SCIENCE COMPANY GMBH
    Inventors: Leendert W. Neuteboom, John A. McElver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle
  • Publication number: 20230049124
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: September 16, 2022
    Publication date: February 16, 2023
    Inventors: Leendert W. NEUTEBOOM, John A. Mcelver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle
  • Publication number: 20230024869
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: September 16, 2022
    Publication date: January 26, 2023
    Inventors: Leendert W. NEUTEBOOM, John A. McElver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle
  • Publication number: 20220186177
    Abstract: The present invention is directed to an industrial fermentation process for cultivating a Bacillus cell in a chemically defined fermentation medium and a method for producing a protein of inter-est comprising the steps of providing a chemically defined fermentation medium, inoculating the fermentation medium with a Bacillus cell comprising a gene encoding a protein of interest, cultivating the Bacillus cell in the fermentation medium under conditions conductive for the growth of the Bacillus cell and the expression of the protein of interest, wherein the cultivation of the Bacillus cell comprises the addition of one or more feed solutions comprising one or more chemically defined carbon sources and magnesium ions to the fermentation medium.
    Type: Application
    Filed: February 18, 2020
    Publication date: June 16, 2022
    Inventors: Andreas Daub, Aydin Golabgir Anbarani, Tobias Klein, Stephan Freyer, Thomas Kaeding, Max Fabian Felle, Paul Igor Costea
  • Publication number: 20220186234
    Abstract: The present invention is directed to an industrial fermentation process for cultivating a Bacillus cell in a chemically defined fermentation medium and a method for producing a protein of interest comprising the steps of providing a chemically defined fermentation medium, inoculating the fermentation medium with a Bacillus cell comprising a gene encoding a protein of interest, cultivating the Bacillus cell in the fermentation medium under conditions conductive for the growth of the Bacillus cell and the expression of the protein of interest, wherein the cultivation of the Bacillus cell comprises the addition of one or more feed solutions comprising one or more chemically defined carbon sources and one or more trace element ions to the fermentation medium.
    Type: Application
    Filed: February 18, 2020
    Publication date: June 16, 2022
    Inventors: Andreas Daub, Aydin Golabgir Anbarani, Tobias Klein, Stephan Freyer, Thomas Kaeding, Max Fabian Felle, Paul Igor Costea
  • Patent number: 11066653
    Abstract: The present invention is directed to a producing a DNA methyltransferase in a recombinant host cell, wherein the DNA methyltransferase methylates DNA resulting in a DNA containing 5-methylcytosine within the recognition sequence GCNGC and wherein the DNA methyltransferase comprises less than (35) amino acid residues between amino acid residue (72) and amino acid residue (106) according to the numbering of SEQ ID NO: 33. Furthermore, the present invention is directed to the use of such DNA methyltransferase for the production of bacterial transformants comprising the steps of (a) introducing into a first bacterial host cell a polynucleotide comprising a polynucleotide sequence encoding the DNA methyltransferase to produce a methylated DNA and (b) transferring the methylated DNA from the first bacterial host cell into a second bacterial host cell, wherein the second bacterial host cell comprises a restriction endonuclease able to degrade the DNA but unable to degrade the methylated DNA.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: July 20, 2021
    Assignee: BASF SE
    Inventors: Max Fabian Felle, Stefan Seemayer
  • Publication number: 20200181627
    Abstract: The present invention is directed to a nucleic acid construct comprising a polynucleotide operably linked to one or more control sequence that directs the expression of the polynucleotide in a host cell, wherein at least one control sequence comprises a promoter sequence of an operon comprising a secA gene or a functional fragment or functional variant thereof and wherein said promoter sequence is heterologous to the polynucleotide. In a further embodiment, the invention is directed to an expression vector and a host cell comprising the nucleic acid construct comprising the promoter sequence described herein and a method of expressing a polynucleotide in a host cell.
    Type: Application
    Filed: July 11, 2018
    Publication date: June 11, 2020
    Inventors: Max Fabian Felle, Bogdan Tokovenko
  • Patent number: 10676728
    Abstract: The present invention generally relates to the field of fermentation technology and microorganisms useful for such fermentations. The invention also relates to materials including nucleic acids and proteins useful for altering fermentation characteristics of microorganisms, and to microorganisms comprising such nucleic acids and/or proteins. In particular, the invention relates to materials for conferring, modifying or reducing microbial stress resistance.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: June 9, 2020
    Assignee: BASF SE
    Inventors: Max Fabian Felle, Stefan Jenewein, Stefan Handtke, Birgit Voigt, Thomas Schweder, Michael Hecker
  • Publication number: 20200165581
    Abstract: The present invention is directed to a producing a DNA methyltransferase in a recombinant host cell, wherein the DNA methyltransferase methylates DNA resulting in a DNA containing 5-methylcytosine within the recognition sequence GCNGC and wherein the DNA methyltransferase comprises less than (35) amino acid residues between amino acid residue (72) and amino acid residue (106) according to the numbering of SEQ ID NO: 33. Furthermore, the present invention is directed to the use of such DNA methyltransferase for the production of bacterial transformants comprising the steps of (a) introducing into a first bacterial host cell a polynucleotide comprising a polynucleotide sequence encoding the DNA methyltransferase to produce a methylated DNA and (b) transferring the methylated DNA from the first bacterial host cell into a second bacterial host cell, wherein the second bacterial host cell comprises a restriction endonuclease able to degrade the DNA but unable to degrade the methylated DNA.
    Type: Application
    Filed: July 11, 2018
    Publication date: May 28, 2020
    Inventors: Max Fabian Felle, Stefan Seemayer
  • Publication number: 20190309290
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: April 20, 2017
    Publication date: October 10, 2019
    Inventors: Leendert W. Neuteboom, John A. McElver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle